Atai Life Sciences Revenue 2020-2024 | ATAI
Atai Life Sciences revenue from 2020 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Atai Life Sciences Annual Revenue (Millions of US $) |
2023 |
$0 |
2022 |
$0 |
2021 |
$20 |
2020 |
$ |
2019 |
$ |
Atai Life Sciences Quarterly Revenue (Millions of US $) |
2024-06-30 |
$0 |
2024-03-31 |
|
2023-12-31 |
$0 |
2023-09-30 |
$0 |
2023-06-30 |
$0 |
2023-03-31 |
$0 |
2022-12-31 |
$0 |
2022-09-30 |
$0 |
2022-06-30 |
$0 |
2022-03-31 |
|
2021-12-31 |
$0 |
2021-09-30 |
$0 |
2021-06-30 |
|
2021-03-31 |
$20 |
2020-12-31 |
|
2020-09-30 |
|
2020-06-30 |
|
2020-03-31 |
|
2019-12-31 |
|
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Outpatient & Home Care |
$0.198B |
$0.000B |
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
|